Arrowhead Pharmaceuticals To Rally Over 44%? Here Are 10 Top Analyst Forecasts For Tuesday
Benzinga·04/21/2026 11:56:31
Listen to the news
Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- B of A Securities raised the price target for CMS Energy Corp (NYSE:CMS) from $82 to $88. B of A Securities analyst Ross Fowler maintained a Buy rating. CMS Energy shares closed at $77.04 on Monday. See how other analysts view this stock.
- Goldman Sachs raised Ramaco Resources Inc (NASDAQ:METC) price target from $14 to $15. Goldman Sachs analyst Brian Lee upgraded the stock from Sell to Neutral. Ramaco Resources shares closed at $14.07 on Monday. See how other analysts view this stock.
- Truist Securities slashed price target for Packaging Corp Of America (NYSE:PKG) from $267 to $260. Truist Securities analyst Michael Roxland maintained a Buy rating. Packaging Corp shares closed at $213.41 on Monday. See how other analysts view this stock.
- Baird slashed the price target for Mohawk Industries Inc (NYSE:MHK) from $156 to $118. Baird analyst Timothy Wojs downgraded the stock from Outperform to Neutral. Mohawk Industries shares closed at $109.51 on Monday. See how other analysts view this stock.
- Needham raised Crocs Inc (NASDAQ:CROX) price target from $118 to $132. Needham analyst Tom Nikic maintained a Buy rating. Crocs shares closed at $111.19 on Monday. See how other analysts view this stock.
- HC Wainwright & Co. raised Century Therapeutics Inc (NASDAQ:IPSC) price target from $2 to $5. HC Wainwright & Co. analyst Mitchell S. Kapoor maintained a Buy rating. Century Therapeutics shares closed at $2.34 on Monday. See how other analysts view this stock.
- Keefe, Bruyette & Woods raised SmartFinancial Inc (NYSE:SMBK) price target from $42 to $46. Keefe, Bruyette & Woods analyst Catherine Mealor maintained a Market Perform rating. SmartFinancial shares closed at $42.76 on Monday. See how other analysts view this stock.
- Morgan Stanley raised the price target for Arrowhead Pharmaceuticals Inc (NASDAQ:ARWR) from $78 to $100. Morgan Stanley analyst Michael Ulz upgraded the stock from Equal-Weight to Overweight. Arrowhead Pharmaceuticals shares closed at $69.25 on Monday. See how other analysts view this stock.
- B of A Securities cut Leidos Holdings Inc (NYSE:LDOS) price target from $235 to $200. B of A Securities analyst Mariana Perez maintained a Buy rating. Leidos shares closed at $154.82 on Monday. See how other analysts view this stock.
- B of A Securities raised Antero Resources Corp (NYSE:AR) price target from $39 to $44. B of A Securities analyst Kalei Akamine maintained a Buy rating. Antero Resources shares closed at $36.57 on Monday. See how other analysts view this stock.
Considering buying ARWR stock? Here’s what analysts think:
Photo via Shutterstock
Contact Us
Contact Number :+852 3852 8500Monday 7:00 AM - Saturday 9:00 AM (HKT)
Service Email :service@webull.hkOnline Support: Monday - Friday: 9:00 - 16:00; 22:30 - 5:00 (HKT)
Business Cooperation :marketinghk@webull.hkRisk Disclosure: The content of this page is not an investment advice and does not constitute any offer or solicitation to offer or recommendation of any investment product. It is for general purposes only and does not take into account your individual needs, investment objectives and specific financial circumstances. All investments involve risk and the past performance of securities, or financial products does not guarantee future results or returns. Keep in mind that while diversification may help spread risk it does not assure a profit, or protect against loss, in a down market. There is always the potential of losing money when you invest in securities, or other financial products. Investors should consider their investment objectives and risks carefully before investing. For more details, please refer to risk disclosure.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Webull Securities Limited is licensed with the Securities and Futures Commission of Hong Kong (CE No. BNG700) for carrying out Type 1 License for Dealing in Securities, Type 2 License for Dealing in Futures Contracts and Type 4 License for Advising on Securities.
Language
English
©2026 Webull Securities Limited. All rights reserved.